M. Bouras et al., VARIABILITY OF HA-RAS (CODON 12) PROTOONCOGENE MUTATIONS IN DIVERSE THYROID CANCERS, European journal of endocrinology, 139(2), 1998, pp. 209-216
Structural alterations to proto-oncogene sequences may be involved in
the pathogenesis of human thyroid neoplasms. We studied 128 thyroid tu
mours (35 benign and 93 malignant) for las gene point mutations in thr
ee different codons (12, 13 and 61) using a restriction fragment lengt
h polymorphism technique and direct sequencing of double-stranded DMA
on polymerase chain-reaction-amplified tumour DNA. We found a high fre
quency of ras mutation for the Ha-ras codon 12 in follicular adenomas
(7 of 35), particularly in atypical adenomas (5 of 17), in follicular
carcinomas (6 of 19), with a high percentage for Hurthle cell carcinom
as (6 of 11), and in papillary carcinomas (4 of 66), Point mutations f
or other ras genes in different codons studied were weak to absent. No
mutation was found in undifferentiated carcinomas (n = 8). The predom
inant amino acid substitution both in the adenomas and in the differen
tiated rumours was glycine to valine (GGC to GTC) at position 12 of th
e Ha-ras gene. Our results obtained on a large series confirm the freq
uent occurrence of Ha-ras codon 12 gene mutations both in adenomas and
in carcinomas. The frequency of ras mutations is linked to the geogra
phical origin of the population studied, and varies (0-85%) from one c
ancer type to another according to published data. Therefore, these mu
tations are merely an expression of cellular transformation.